- Home
- JAZZ vs TRU Comparison
JAZZ vs TRU Comparison
Compare JAZZ & TRU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JAZZ | TRU |
|---|---|---|
| Founded | 2003 | 1968 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.1B | 14.2B |
| IPO Year | 2007 | 2013 |
Fundamental Metrics
Financial Performance| Metric | JAZZ | TRU |
|---|---|---|
| Price | $244.79 | $80.29 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 22 | 22 |
| Target Price | ★ $295.86 | $90.29 |
| AVG Volume (30 Days) | 771.2K | ★ 3.2M |
| Earning Date | 11-02-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 0.66% |
| EPS Growth | N/A | ★ 60.00 |
| EPS | 0.04 | ★ 3.59 |
| Revenue | $1,618,693,000.00 | ★ $4,576,300,000.00 |
| Revenue This Year | $12.59 | $12.66 |
| Revenue Next Year | $5.11 | $5.90 |
| P/E Ratio | $6,151.50 | ★ $22.84 |
| Revenue Growth | N/A | ★ 9.38 |
| 52 Week Low | $136.56 | $60.96 |
| 52 Week High | $266.38 | $89.12 |
Technical Indicators
Market Signals| Indicator | JAZZ | TRU |
|---|---|---|
| Relative Strength Index (RSI) | 65.72 | 56.95 |
| Support Level | $236.70 | $71.35 |
| Resistance Level | $250.49 | $81.46 |
| Average True Range (ATR) | 7.18 | 3.21 |
| MACD | 4.64 | 0.29 |
| Stochastic Oscillator | 95.81 | 66.16 |
Price Performance
Historical ComparisonAbout JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
About TRU TransUnion
TransUnion, along with Equifax and Experian, is one of the three leading credit bureaus in the United States, providing the consumer information that is the basis for granting credit. The company also provides fraud detection, marketing, and analytical services. TransUnion operates in over 30 countries. About 20%-25% of its revenue comes from international markets.